Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Biosciences Q2 Revenue USD 9.232 Million

Aug 07 (Reuters) - Interpace Biosciences Q2 operating income USD -468 thousand.

Q2 gross profit USD 5.276 million

Q2 net income USD -640 thousand

Q2 operating expenses USD 5.744 million

Recent news on Interpace Biosciences

See all news